These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10594394)
1. A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis. Egan LJ; Sandborn WJ; Tremaine WJ; Leighton JA; Mays DC; Pike MG; Zinsmeister AR; Lipsky JJ Aliment Pharmacol Ther; 1999 Dec; 13(12):1597-604. PubMed ID: 10594394 [TBL] [Abstract][Full Text] [Related]
2. [Reccomendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the use of methotrexate in inflammatory bowel disease]. Gomollón F; Rubio S; Charro M; García-López S; Muñoz F; Gisbert JP; Domènech E; Gastroenterol Hepatol; 2015 Jan; 38(1):24-30. PubMed ID: 25454602 [TBL] [Abstract][Full Text] [Related]
3. A single center experience of methotrexate in the treatment of Crohn's disease and ulcerative colitis: a case for subcutaneous administration. Nathan DM; Iser JH; Gibson PR J Gastroenterol Hepatol; 2008 Jun; 23(6):954-8. PubMed ID: 17559377 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative Colitis. Carbonnel F; Colombel JF; Filippi J; Katsanos KH; Peyrin-Biroulet L; Allez M; Nachury M; Novacek G; Danese S; Abitbol V; Bossa F; Moreau J; Bommelaer G; Bourreille A; Fumery M; Roblin X; Reinisch W; Bouhnik Y; Brixi H; Seksik P; Malamut G; Färkkilä M; Coulibaly B; Dewit O; Louis E; Deplanque D; Michetti P; Sarter H; Laharie D; ; Gastroenterology; 2016 Feb; 150(2):380-8.e4. PubMed ID: 26632520 [TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and pharmacokinetics after addition of low-dose cyclosporine to methotrexate: a case study of five patients with treatment-resistant inflammatory bowel disease. Egan LJ; Tremaine WJ; Mays DC; Lipsky JJ; Sandborn WJ Inflamm Bowel Dis; 2000 Nov; 6(4):286-9. PubMed ID: 11149561 [TBL] [Abstract][Full Text] [Related]
8. Azathioprine or methotrexate in the treatment of patients with steroid-dependent or steroid-resistant ulcerative colitis: results of an open-label study on efficacy and tolerability in inducing and maintaining remission. Paoluzi OA; Pica R; Marcheggiano A; Crispino P; Iacopini F; Iannoni C; Rivera M; Paoluzi P Aliment Pharmacol Ther; 2002 Oct; 16(10):1751-9. PubMed ID: 12269968 [TBL] [Abstract][Full Text] [Related]
9. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Kozarek RA; Patterson DJ; Gelfand MD; Botoman VA; Ball TJ; Wilske KR Ann Intern Med; 1989 Mar; 110(5):353-6. PubMed ID: 2492786 [TBL] [Abstract][Full Text] [Related]
11. Use of methotrexate in patients with inflammatory bowel diseases. Preiss JC; Zeitz M Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S151-5. PubMed ID: 21044450 [TBL] [Abstract][Full Text] [Related]
12. Safety profile of methotrexate in inflammatory bowel disease. Gabbani T; Deiana S; Lunardi S; Manetti N; Annese V Expert Opin Drug Saf; 2016 Oct; 15(10):1427-37. PubMed ID: 27462711 [TBL] [Abstract][Full Text] [Related]
13. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA; McDonald JW; Feagan BG Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate for induction of remission in refractory Crohn's disease. Alfadhli AA; McDonald JW; Feagan BG Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475 [TBL] [Abstract][Full Text] [Related]
15. Vedolizumab provides clinical benefit over 1 year in patients with active inflammatory bowel disease - a prospective multicenter observational study. Stallmach A; Langbein C; Atreya R; Bruns T; Dignass A; Ende K; Hampe J; Hartmann F; Neurath MF; Maul J; Preiss JC; Schmelz R; Siegmund B; Schulze H; Teich N; von Arnim U; Baumgart DC; Schmidt C Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1199-1212. PubMed ID: 27714831 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate for induction of remission in ulcerative colitis. Chande N; MacDonald JK; McDonald JW Cochrane Database Syst Rev; 2007 Oct; (4):CD006618. PubMed ID: 17943916 [TBL] [Abstract][Full Text] [Related]
17. Pulse cyclophosphamide therapy for inflammatory bowel disease. Barta Z; Tóth L; Zeher M World J Gastroenterol; 2006 Feb; 12(8):1278-80. PubMed ID: 16534885 [TBL] [Abstract][Full Text] [Related]
18. Low-dosage methotrexate for treatment and maintenance of remission in patients with inflammatory bowel disease. Vandell AG; DiPiro JT Pharmacotherapy; 2002 May; 22(5):613-20. PubMed ID: 12013360 [TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety and tolerability of vidofludimus in patients with inflammatory bowel disease: the ENTRANCE study. Herrlinger KR; Diculescu M; Fellermann K; Hartmann H; Howaldt S; Nikolov R; Petrov A; Reindl W; Otte JM; Stoynov S; Strauch U; Sturm A; Voiosu R; Ammendola A; Dietrich B; Hentsch B; Stange EF J Crohns Colitis; 2013 Sep; 7(8):636-43. PubMed ID: 23078909 [TBL] [Abstract][Full Text] [Related]